Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
消食养胃片 (Xiaoshi Yangwei Pian) is a traditional Chinese medicine (TCM) oral tablet developed and marketed by Henan Bainian Kangxin Pharmaceutical. It is indicated for the treatment of indigestion and dyspepsia, adhering to traditional Chinese medicine principles of nourishing the stomach and promoting digestion. As a TCM formulation, it typically comprises a blend of herbal ingredients designed to improve gastrointestinal function and alleviate symptoms associated with poor digestion. The product is an approved medication in China, distributed primarily through franchise and retail channels by Henan Bainian Kangxin Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 消食养胃片.